期刊文献+

糖化血红蛋白检测对糖尿病诊治和控制的临床应用价值 被引量:1

下载PDF
导出
摘要 目的探究糖化血红蛋白检测于糖尿病诊治和控制中的临床应用价值。方法本课题收集我院内科收治的已确诊的糖尿病患者30例作为观察对象,予以患者糖化血红蛋白检测。结果糖化血红蛋白检测开展后空腹血糖为及糖化血红蛋白指标异于开展前,差异有统计学意义(P<0.05)。结论糖化血红蛋白检测可作为糖尿病诊治的主要指标,糖化血红蛋白检测临床应用价值较高。
作者 王丽娟
出处 《实用妇科内分泌电子杂志》 2019年第34期141-141,共1页 Electronic Journal of Practical Gynecological Endocrinology
  • 相关文献

参考文献3

二级参考文献31

  • 1Degano IR,Subirana I,Torre M,et al.A European benchmarking system to evaluate in-hospital mortality rates in acute coronary syndrome:The EURHOBOP project.Int J Cardiol,2015,182:509-516. 被引量:1
  • 2Kurtul A.Murat SN,Yarlioglues M,et al.Increased neutrophil-to-lymphocyte ratio predicts persistent coronary no-flow after wire insertion in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.Clinics(Sao Paulo),2015,70:34-40. 被引量:1
  • 3Arnold SV.Lipska KJ.Inzucchi SE,et al.The reliability of inhospital diagnoses of diabetes mellitus in the setting of an acute myocardial infarction.BMJ Open Diabetes Res Care,2014,2:e000046. 被引量:1
  • 4Tartan Z,Ozer N,Uyarel H,et al.Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction.Nutr Metab Cardiovasc Dis,2008,18:441-447. 被引量:1
  • 5Zhao JL,Fan CM,Yang YJ.et al.Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.Cardiovasc Ther,2013,31:60-64. 被引量:1
  • 6Yildiz A,Arat-Ozkan A.Kocas C,et al.Admission hyperglycemia and TIMI frame count in primary percutaneous coronary intervention.Angiology,2012,63:325-329. 被引量:1
  • 7Fujino M,Ishihara M,Honda S,et al.Impact of acute and chronic hyperglycemia on in-hospital outcomes of patients with acute myocardial infarction.Am J Cardiol,2014,114:1789-1793. 被引量:1
  • 8Hunt KJ,Baker N.Cleary P,et al.Oxidized LDL and AGELDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.Atherosclerosis,2013,231:315-322. 被引量:1
  • 9Zhu L,He Z,Wu F,et al.Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice.Cardiovasc Diabetol,2014,13:151-154. 被引量:1
  • 10Hodgkinson CP.Laxton RCPatel K,et al.Advanced glycation end-product of low density lipoprotein activates the tolllike 4 receptor pathway implications for diabetic atherosclerosis.Arterioscler Thromb Vase Biol,2008,28:2275-2281. 被引量:1

共引文献42

同被引文献18

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部